Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 4,546 | 26,082 | 14,417 | 13,794 | 10,891 |
| Cost of Goods | 12,794 | 12,079 | 9,199 | 11,166 | 9,880 |
| Gross Profit | -8,248 | 14,003 | 5,218 | 2,628 | 1,011 |
| Operating Expenses | 176,313 | 112,436 | 105,960 | 99,134 | 100,821 |
| Operating Income | -183,767 | -98,354 | -100,543 | -96,340 | -98,930 |
| Other Income | 4,869 | 2,679 | 2,480 | 4,188 | 1,872 |
| Pre-tax Income | -178,898 | -95,675 | -98,063 | -92,152 | -97,058 |
| Income Tax | 8 | 167 | -523 | -779 | N/A |
| Net Income Continuous | -178,906 | -95,842 | -97,540 | -91,373 | -92,996 |
| Net Income | $-178,906 | $-95,842 | $-97,540 | $-91,373 | $-92,996 |
| EPS Basic Total Ops | -0.56 | -0.34 | -0.40 | -0.39 | -0.43 |
| EPS Basic Continuous Ops | -0.56 | -0.34 | -0.40 | -0.39 | -0.42 |
| EPS Diluted Total Ops | -0.56 | -0.34 | -0.40 | -0.39 | -0.43 |
| EPS Diluted Continuous Ops | -0.56 | -0.34 | -0.40 | -0.39 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.53 | -0.34 | -0.40 | N/A | N/A |
| EBITDA(a) | $-170,816 | $-91,156 | $-91,575 | $-88,963 | $-91,377 |